Pharma Market Insight & Strategy - 2013 Edition
Pharma Market Insight & Strategy - 2013 Edition, provides a fact-based analysis of the evolution of the pharmaceutical market through the end of 2017 and evaluates the performance and strategy of 30 leading pharmaceutical companies.
The author shares his strategic vision of where the pharmaceutical market is headed and the strategies that pharmaceutical companies can adopt to succeed – with particular emphasis on the performance and corresponding strategic priorities of the Big Pharma and Mid Pharma companies.
Key facts and figures corresponding to each of the 30 analyzed pharmaceutical companies have been summarized into one-page identity cards, providing a concise, powerful snapshot of each firm for easy review and comparison.
Section 1: Pharma Market Insight analyzes the following themes:
- The pharma market features (global historic trends, sector performance, leading pharma companies, corporate reputation, biotech, vaccines, generics, biosimilars, OTC)
- The pharma market drivers and limiters
- The strategic options for leading pharma companies
Section 2: Performance & Strategy of Leading Pharma Companies evaluates whether the size of companies has an impact on their performance and their strategic orientation, through the analysis of seven criteria:
- Key financial data (revenues and profits)
- Strategic segments coverage
- Portfolio structure
- Geographical coverage
- R&D investments
- Business development
- Strategic priorities
Section 3: Leading Pharma Companies at a Glance provides a one-page strategic identity card for 30 leading pharma companies
About the author
Jean-Michel Peny is President of the Strategy and Management consulting firm Smart Pharma Consulting, Director of Smart Pharma Institute of Management, Lecturer in Pharmaceutical Strategy and Marketing at the ESCP Europe and ESSEC Business Schools, the Faculty of Pharmaceutical Sciences (Paris XI) and the Faculty of Medicine (Paris VI).
Prior to founding Smart Pharma Consulting in 2001, Jean-Michel advised many of the leading global pharmaceutical companies during his 19 years as a Strategy and Management consultant with Bain & Co, AT Kearney, Arthur D.Little, and ISO HealthCare Group. Prior to his consulting career, Jean-Michel was a General Manager in the pharmaceutical industry for over seven years with Servier and Novartis.
Jean-Michel holds a doctorate in Pharmaceutical Sciences from the University of Nantes, a master in International Business from the University of Lyon III and an MBA from HEC Business School.
He is a former affiliate professor at HEC Business School and has published over 40 articles on business issues related to the pharmaceutical industry, as well as several books: "Pharma Market Insight & Strategy" (2012), "Pharma Companies Strategies, Key Facts & Figures" (2011), “Pharma Market Insights” (2010), “Pharma Marketing Tool Box” (2008), and co-authored "Le marketing du médicament en question(s)" (Vuibert-2008).
Wire-bound handbook: 200 pages
Publisher: Smart Pharma Consulting (November 2013)
Price: 300 € (excl. tax)